46 studies found for:    " January 06, 2010":" February 05, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" January 06, 2010":" February 05, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (46 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
Conditions: HIV Infection;   HIV Infections
Intervention: Genetic: SB-728-T
2 Completed HIV Treatment and CVD Events
Conditions: HIV Infection;   Cardiovascular Disease;   Infection, Human Immunodeficiency Virus;   Acute Myocardial Infarction
Intervention: Drug: HAART Treatment
3 Completed TMC114-TiDP3-C182 - A Study to Compare the Oral Bioavailability of a 800 mg Prototype Tablet Formulation of Darunivar (DRV) to That of the 400 mg Commercial Tablet Formulation in the Presence of Low Dose Ritonavir, Under Fasted and Fed Conditions
Condition: HIV Infections
Intervention: Drug: DRV commercial formulation/ DRV new formulation/ rtv 100mg tab
4 Completed
Has Results
Management of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138)
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: ARV (non-raltegravir)
5 Completed The Impact of Short Message Services (SMS) on ARV Adherence in Western Kenya
Conditions: AIDS;   Antiretroviral Therapy;   Medication Adherence;   HIV Infections
Intervention: Behavioral: Short Message Services to Support ARV therapy adherence
6 Unknown  Notification of Donors With Positive Microbiology Markers
Conditions: Human Immunodeficiency Virus;   Hepatitis B;   Hepatitis C;   Human T-lymphotropic Virus I & II;   Creutzfeldt-Jakob Syndrome;   HIV Infections
Intervention:
7 Completed Preventative Misconception Intervention
Conditions: HIV;   HIV Infections
Interventions: Behavioral: 1-sided messages;   Behavioral: 2-sided messages
8 Completed
Has Results
Fosamprenavir in Pts With Hepatic Impairment
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Intervention A Standard dose;   Drug: Intervention B Reduced Dose;   Drug: Intervention C;   Drug: Intervention D;   Drug: Intervention E
9 Active, not recruiting Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries
Condition: HIV Infections
Interventions: Drug: Zidovudine (ZDV);   Drug: Nevirapine (NVP);   Drug: Emtricitabine-tenofovir disoproxil fumarate (Truvada [TRV]);   Drug: Lamivudine-Zidovudine (3TC-ZDV);   Drug: Lopinavir-ritonavir (LPV-RTV)
10 Withdrawn An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons
Conditions: HIV;   HIV Infections
Intervention: Drug: Valacyclovir
11 Completed Cell Phone Reminders Intervention
Conditions: HAART Non-Adherence;   HIV;   HIV Infections
Intervention: Behavioral: Cell Phone Intervention
12 Completed Treatment for Depression Among HIV-Infected Youth
Conditions: HIV;   Depression;   HIV Infections
Interventions: Behavioral: COMB - Combination Cognitive Behavioral Therapy and Medication Management;   Behavioral: TAU - Treatment as Usual
13 Completed Effect of Seminal Fluid on the Colon Wall; Implications for HIV Transmission
Condition: Human Immunodeficiency Virus (HIV)
Interventions: Biological: Autologous seminal fluid with Tc-99m/In-111 radiolabels;   Other: Autologous lymphocytes labeled with In-111 in normosol vehicle with TC-99m DTPA incorporated
14 Completed A Study To Investigate The Clearance Of PF-04776548 From The Body Following A Very Low (Micro) Dose Of The Compound Using A Low Level Of Radiotracer To Help Quantify Expected Low Concentrations Of PF-04776548 In The Body
Condition: Human Immunodeficiency Virus (HIV)
Intervention: Drug: PF-04776548
15 Unknown  High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk
Conditions: HIV-related Lymphoma;   HIV Infections
Intervention: Other: Rituximab and CHOP regimen + PBSCT
16 Active, not recruiting Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma
Conditions: AIDS-Related Kaposi Sarcoma;   Recurrent Kaposi Sarcoma
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Lenalidomide
17 Terminated Pre-Exposure Prophylaxis Using TMC278LA
Condition: HIV Infections
Intervention: Drug: TMC278LA
18 Active, not recruiting Examining the Role of Genetics in Determining the Immune Response to an HIV Vaccine in HIV-Uninfected Adult Twins
Condition: HIV Infections
Interventions: Biological: HIV-1 DNA plasmid vaccine;   Biological: HIV-1 recombinant Ad5 vaccine
19 Terminated Impact of Maraviroc on the Immune Function in HIV-1 Infected Subjects Receiving Immunisation With Novel Antigens
Condition: HIV Infections
Interventions: Drug: Maraviroc;   Drug: placebo
20 Completed Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria
Conditions: HIV Infections;   Proteinuria
Intervention: Drug: change from tenofovir to raltegravir

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years